ID: ALA5172018

Max Phase: Preclinical

Molecular Formula: C13H13IO2S3

Molecular Weight: 297.45

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2c/c(=[S+]/CC(C)=O)ss2)cc1.[I-]

Standard InChI:  InChI=1S/C13H13O2S3.HI/c1-9(14)8-16-13-7-12(17-18-13)10-3-5-11(15-2)6-4-10;/h3-7H,8H2,1-2H3;1H/q+1;/p-1

Standard InChI Key:  NCKUHKUWOSMSDA-UHFFFAOYSA-M

Associated Targets(non-human)

Triosephosphate isomerase, glycosomal 493 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 297.45Molecular Weight (Monoisotopic): 297.0072AlogP: 3.69#Rotatable Bonds: 4
Polar Surface Area: 26.30Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.33CX LogD: 1.33
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.49Np Likeness Score: -0.12

References

1. Beltran-Hortelano I, Alcolea V, Font M, Pérez-Silanes S..  (2022)  Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.,  58  [PMID:35189560] [10.1016/j.bmc.2021.116577]

Source